Levothyroxine: conventional and novel drug delivery formulations

H Liu, W Li, W Zhang, S Sun, C Chen - Endocrine Reviews, 2023 - academic.oup.com
Although levothyroxine is one of the most prescribed medications in the world, its
bioavailability has been reported to be impaired by many factors, including interfering drugs …

Medications and food interfering with the bioavailability of levothyroxine: A systematic review

H Liu, M Lu, J Hu, G Fu, Q Feng, S Sun… - … and Clinical Risk …, 2023 - Taylor & Francis
Purpose Levothyroxine is a common prescribed drug. Many medications and food, however,
can interfere with its bioavailability. The aim of this review was to summarize the …

Advances in molecular pathophysiology and targeted therapy for Cushing's disease

S Takayasu, K Kageyama, M Daimon - Cancers, 2023 - mdpi.com
Simple Summary Cushing's disease is caused by autonomous adrenocorticotropic hormone
(ACTH) produced by corticotroph pituitary neuroendocrine tumors, leading to cortisol over …

Mifepristone-Induced Hypothyroidism

N Kalara, A Manzano - Journal of Investigative Medicine …, 2023 - journals.sagepub.com
Medications are known to affect the thyroid physiology and are a known cause of
hypothyroidism. There is an ever-growing list of medications that affect the thyroid by 1 or …

[HTML][HTML] Cushing Disease (Nursing)

N Kairys, C Anastasopoulou, A Schwell… - StatPearls …, 2023 - ncbi.nlm.nih.gov
Cushing disease is a rare disorder characterized by increased adrenocorticotropic hormone
(ACTH) production from the anterior pituitary, leading to excess cortisol release from the …